Table IV.
Mean fold change in gene expressiona | ||||
---|---|---|---|---|
Gene | Annotation (DFCI accession / GenBank accession) | DBC b | DBC+Chl c | Chl d |
Growth factor | ||||
FGF6 | NP544420 / Y16850 | −1.00 | - | - |
Immune response | ||||
IGF1 | NP544251 / M95183 | −1.25 | - | - |
LECT2 | TC154068 / AF363272 | −1.15 | - | |
Metabolism | ||||
Vtg1 | TC132491 / X92804 | −1.20 | - | - |
Extracellular matrix | ||||
MMP | TC147381 / AB043536 | −1.26 | - | - |
Mean fold changes in gene expression were log2 transformed. Only probes that differed by an average of at least twofold between treatment and control groups and were significant (P<0.05) are reported.
224 ppm DBC was administered via the diet for 20 days and liver samples for RNA were collected at the end of the 20 day exposure period.
224 ppm DBC + 2000ppm Chl were co-administered via the diet for 20 days and liver samples for RNA were collected at the end of the 20 day exposure period.
2000 ppm Chl were co-administered via the diet for 20 days and liver samples for RNA were collected at the end of the 20 day exposure period.